May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Chamber Angle Pigmentation after Long Term Latanoprost Treatment for Glaucoma
Author Affiliations & Notes
  • Y. Nakamura
    Department of Ophthalmology, Ryukyu Univ School of Med, Nishihara-cho, Japan
  • Y. nakamura
    Department of Ophthalmology, Ryukyu Univ School of Med, Nishihara-cho, Japan
  • H. Sakai
    Department of Ophthalmology, Ryukyu Univ School of Med, Nishihara-cho, Japan
  • S. Sawaguchi
    Department of Ophthalmology, Ryukyu Univ School of Med, Nishihara-cho, Japan
  • Footnotes
    Commercial Relationships  Y. Nakamura, None; Y. nakamura, None; H. Sakai, None; S. Sawaguchi, None.
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 2205. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Y. Nakamura, Y. nakamura, H. Sakai, S. Sawaguchi; Chamber Angle Pigmentation after Long Term Latanoprost Treatment for Glaucoma . Invest. Ophthalmol. Vis. Sci. 2003;44(13):2205.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To examine prospectively the change of chamber angle pigmentation and the efficacy of latanoprost in the long-term treatment for glaucoma patients for 3 years. Patients and Methods: Forty-one Japanese glaucoma patients of ocular hypertension, primary open angle glaucoma and normal tension glaucoma were treated with latanoprost for more than 36 months.Gonioscopic photographs of lower quadrant were taken in all patients at pre-latanoprost treatment, at every 3-months for 1 year and every 6-months for 2 years after latanoprost treatment. 3 glaucoma specialists examined Gonioscopic photographs after 3 years follow up in a masked manner. Intra ocular pressure (IOP) was measured over the 36-months treatment period, and adverse events were evaluated. Results: No pigmentary change at chamber angle was observed for 36 months follow up period. Ten patients showed increased iris pigmentation and 3 cases showed eyelash changes. Latanoprost significantly reduced (PÅÉ0.001) IOP by approximately 3.6mmHg from initial pretreatment value at 3 months and this reduction continued over 36-months without signs of upward drift. Conclusions: Latanoprost, administered once daily, did not give any pigmentary change at chamber angle in all 41 glaucoma patients, even in 10 patients with increased iris pigmentation for 3 years. Latanoprost is also effective on lowering IOP for Japanese glaucoma patients up to 3 years.

Keywords: anterior chamber • drug toxicity/drug effects • intraocular pressure 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×